Cephulac (Lactulose) CAS 4618-18-2

Comprehensive Guide to Cephulac (Lactulose) CAS 4618-18-2

Table of Contents

• Product Overview & Specifications
• Detailed Applications
• Usage Guidelines
• Industry Case Studies
• Client Implementation Examples
• Contact for Technical Consultation

Product Specifications & Comparative Analysis

Therapeutic & Industrial Applications

Medical Applications

• Chronic Constipation Management: Osmotic laxative for all age groups
• Hepatic Encephalopathy: Reduces blood ammonia levels by 25-50%
• Prebiotic Formulations: Stimulates bifidobacteria growth (3-5x increase)

Pharmaceutical Manufacturing

• Stable excipient for oral solutions
• Syrup formulations (67-70% concentration)
• Pediatric medication base

Optimal Usage Protocols

Documented Clinical Outcomes

Case Study 1: Hospital Hepatic Care

• Client: Berlin Central Hospital
• Challenge: Refractory hepatic encephalopathy cases
• Solution: High-dose Cephulac protocol (45ml q6h)
• Outcome: 78% reduction in ICU admissions

Case Study 2: Geriatric Care Facility

• Client: SilverCare Nursing Homes
• Challenge: Opioid-induced constipation
• Protocol: 10ml BID maintenance dosing
• Result: 92% bowel regularity improvement

Manufacturing Implementations

Pharma Production – Madrid

• Client: IberPharma Solutions
• Application: Stable syrup formulation
• Technical Specs:
  • Batch Size: 2,000L
  • pH Stability: 3.2-4.5 range
  • Shelf Life: 36 months

Technical Consultation & Ordering

Why Choose Our Cephulac Supply?

• GMP-certified production
• Custom concentration options (30-70%)
• Global cold-chain logistics

Contact our pharmaceutical experts:
Email: info@vivalr.com
Tel: (86) 15866781826

Request Formulation Guidance:

• Specify required CAS documentation
• Request stability test data
• Ask about bulk pricing tiers